成都百事兴科技实业有限公司始建于2003年，公司占地面积18000余平米，位于成都市蒲江县鹤山镇工业北路217号。2011年进行了aa期技术改造工程，新建氨基酸生产线两条、医药中间体生产线一条，按照**GMP标准建造生产车间5000余平米。通过近9年的升级技术改造达到预期的效果，生产经营得到了很大的提升，先后被评为四川省高新技术企业、四川省中小企业协会理事单位、四川省建设创新型试点企业。。公司多个产品被评为成都市“名优产品”;拥有多个发明aa和实用新型aa，部分产品填补了国内空白。公司已通过ISO9001：2015质量体系**、ISO14001:2015环境管理体系**、ISO22000:2005食品安全管理体系**、OHSAS18001：2007职业健康安全管理体系**。公司于2018年通过了安全标准化二级达标。

      成都百事兴共有两个生产基地，占地面积18000余平米，职工人数近200人，年产量1000吨以上，年销售额1亿元以上。现有4条生产线的成都基地；另一个是位于兰州占地90亩，即将拥有6条符合cGMP生产线的兰州基地。主要产品有：乳清酸、DL-高半胱氨酸硫内酯盐酸盐、双甘肽、甘氨酰酪氨酸、丙氨酰胱氨酸、甘氨酸叔丁酯盐酸盐、D-赖氨酸盐酸盐、D-苏氨酸、L-酪氨酸二钠、L-焦谷氨酸、乙酰 L-硫代脯氨酸、医药中间体等。产品质量按照美国药典（USP）、欧洲药典（EP）、日本味之素（AJI）标准生产；广泛用于医药、食品、化妆品等行业，公司产品覆盖全球20多个**和地区建立了**的**市场网络和良好的对外贸易关系。

      公司始终以创建外向型、科技型的现代企业为发展目标，强化自身建设，扎实做好每项工作，已形成科学的内部管理体系和创新体系；有较强的aa教授、博士、学者组成的产品研发团队；具备成熟的生产工艺、**的检测体系，形成迅速的科技成果转化能力。公司拥有专业、敬业的国内外市场开拓团队，以求实拼搏、**创新的精神应对市场的各种挑战和变化。公司将以aa的技术、aa的产品、aa的服务为人类医药、高端食品行业做贡献。

ABOUT US

Headquarter- Chengdu Beishixing Technology Industrial Co., Ltd.

Established in 2003, Chengdu Beishixing Technology Industrial Co., Ltd. is a high-tech enterprise that provides one-stop production of amino acids, protected amino acids, oligopeptides and other related products. For better human health and development, the company is committed to providing first-class products and services.

Chengdu Baishixing has attracted nearly 200 talents of all types, and its core technology and management team have been deeply involved in this industry for more than 20 years. The company is equipped with advanced instruments and equipment.

Chengdu Baishixing has two production bases. One is a Chengdu base located in Chengdu covering an area of 20 acres and currently has 4 production lines; the other is a Lanzhou base located in Lanzhou covering an area of 90 acres and will soon have 6 cGMP-compliant production lines.

Chengdu Baishixing has obtained ISO9001, ISO14001, ISO22000, OHSAS18001 and other series of certifications all year round. Product quality complies with the standards of Chinese Pharmacopoeia(CP), United States Pharmacopoeia(USP), European Pharmacopoeia(EP) and other countries.

As of 2024, Chengdu Baishixing products and services have covered more than 20 countries and regions around the world. We have established long-term cooperation with well-known domestic and foreign pharmaceutical companies including Pfizer, Sanofi, Merck, Qilu Pharmaceuticals, and Asymchem.

In the field of life sciences, Chengdu Baishixing will spare no effort to provide cost-effective products and services.

Gansu Baishixing Pharmaceutical Co., Ltd.

Established in 2020, located in the national-level new area, Lanzhou New District Chemical Industry Park and covering an area of more than 90 acres, Gansu Baishixing Pharmaceutical Co., Ltd. is the wholly subsidiary of Chengdu Baishixing Science and Technology Industrial Co.,Ltd. The company focuses on the development and production of small molecule drug APIs, high-end pharmaceutical intermediates, and new compounds. It is a high-tech enterprise that provides large-scale products and technical services related to APIs and pharmaceutical intermediates to global pharmaceutical companies and scientific research institutions.

公司使命：为人类健康和发展提供高性价比产品和服务。

公司愿景：成为世界一流生物智造公司。

公司价值观：合规；专注；奋斗；共赢

Company Mission: To  provide affordable high-quality products and services for human health and development.

Company Vision: To be a world-class bio-intelligent manufacturing company.

Company Value: Compliance; Focus;Strive;Win-win

公司历史

2003成立

2011新工厂启用

2015石博士团队加入

2021年营收首次破亿

2023并购甘肃百事兴药业

Company History

2003-Setup

2011-New Factory Operated

2015-Dr Shi and his team joined

2021-Initial Annual Turnover of over 100 million CNY

2023-Acquisition of Gansu Baishixing Pharmaceutical Co., Ltd.